Abstract
With the increasing prevalence and complexity of patients on antiplatelet and anticoagulant therapy, the dental clinician is routinely faced with management of these patients in the practice setting. An understanding of clinical hemostasis and the underlying physiology associated with surgical injury and bleeding allows the clinician to plan and manage preoperative, intraoperative, and postoperative bleeding risk in patients on “blood thinners.” Additionally, a new class of drugs known as “novel oral anticoagulants” creates additional challenges for the dentist and physician when managing these dental patients. In the past, the dental clinician’s initial approach has often been whether to reduce or withdraw medications prior to dental procedures. However, evidence has demonstrated that, in most instances, these patients can and should be maintained on their antiplatelet/anticoagulant regimen when undergoing dental procedures, including dental extractions. Prolonged or increased bleeding in these patients, especially those on single or dual antiplatelet therapy, is generally a manageable challenge or inconvenience but rarely life-threatening. With good communication and planning with the patient’s physician, proper technique, and the use of hemostatic agents, the dental clinician can typically anticipate, plan for, and manage any increased or prolonged bleeding episodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abed HS, Kilborn MJ, Chen V, Sy RW. Reversal agents in the era of NOACs. J Atr Fibrillation. 2017;10:1634.
Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical Hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010;251:217.
ADA. ADA recommendations—anticoagulation and antiplatelet medications and dental procedures. 2018. https://www.ada.org/en/member-center/oral-health-topics/anticoagulant-antiplatelet-medications-and-dental.
Akopov SE, Suzuki S, Fredieu A, Kidwell CS, Saver JL, Cohen SN. Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines? Cerebrovasc Dis. 2005;19:337–42.
Al-Mubarak S, Al-Ali N, Rass AM, Al-Sohail A, Robert A, Al-Zoman K, Al-Suwyed A, Ciancio S. Evaluation of dental extractions, suturing and INR on postoperative bleeding of patients maintained on oral anticoagulant therapy. Br Dent J. 2007;203:E15; bdj.2007.725.
Andresen K, Atar D, Gjertsen E, Ghanima W, Roseth S, Johansen O. Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants. Scand Cardiovasc J. 2018;52(3):156–62.
Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180–90.
Barnes GD, Ageno W, Ansell J, Kaatz S, for the Subcommittee on the Control of Anticoagulation. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13:1154–6.
Branehög I, Ridell B, Swolin B, Weinfeld A. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. Scand J Haematol. 1975;15:321–32.
Brewer A, Correa ME. Treatment of hemophilia: guidelines for dental treatment of patients with inherited bleeding disorders [monograph on the Internet]. Montreál: World Federation of Hemophilia; 2006. p. 40. http://www1.wfh.org/publication/files/pdf-1190.pdf. Accessed 6 June 2018.
Cardona-Tortajada F, Sainz-Gomez E, Figuerido-Garmendia J, de Robles-Adsuar LA, Morte-Casabo A, Giner-Munoz F, Artazcoz-Oses J, Vidan-Lizari J. Dental extractions in patients on antiplatelet therapy. A study conducted by the Oral Health Department of the Navarre Health Service (Spain). Med Oral Patol Oral Cir Bucal. 2009;14:e588–92.
Carter G, Goss A. Tranexamic acid mouthwash—a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg. 2003;32:504–7.
Crowther MA, Warkentin TE. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood. 2008;111:4871–9.
Dalal J, Bhave A, Chaudhry G, Rana P. Reversal agents for NOACs: connecting the dots. Indian Heart J. 2016;68:559–63.
Dézsi B, Koritsánszky L, Braunitzer G, Hangyási D, Dézsi C. Prasugrel versus clopidogrel: a comparative examination of local bleeding after dental extraction in patients receiving dual antiplatelet therapy. J Oral Maxillofac Surg. 2015;73:1894–900.
Dinkova A, Kirova DG, Delev D. Dental management and bleeding complications of patients on long-term oral antiplatelet therapy. Review of existing studies and guidelines. J IMAB. 2013;19:298–304.
Elad S, Marshall J, Meyerowitz C, Connolly G. Novel anticoagulants: general overview and practical considerations for dental practitioners. Oral Dis. 2016;22:23–32.
FDA. Coumadin (warfarin sodium) prescribing information. n.d.-a. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009218s108lbl.pdf.
FDA. Heparin prescribing information. n.d.-b. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017037s158lbl.pdf.
Firriolo JF, Hupp WS. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:431–41.
Frontera JA, Gordon E, Zach V, Jovine M, Uchino K, Hussain MS, Aledort L. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial Hemorrhage. Neurocrit Care. 2014;21:397–406.
Greinacher A, Selleng K, Warkentin T. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2017;15:2099–114.
Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians* *Representation does not imply endorsement by the American College of Physicians. J Am Dent Assoc. 2007;138:652–5.
Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012a;141:53S–70S.
Guyatt GH, Akl EA, Crowther M, Schünemann HJ, Gutterman DD, Lewis S. Introduction to the ninth edition antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012b;141:48S–52S.
Herman WW, Konzelman JL, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. J Am Dent Assoc. 1997;128:327–35.
Howard R, Hamilton J, Britton R. Haematology: an illustrated colour text. Edinburgh: Elsevier; 2013.
Joseph B, Aziz H, Pandit V, et al. Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg. 2014;38:1875–81.
Link K. The discovery of Dicumarol and its sequels. Circulation. 1959;19:97–107.
Malmquist JP. Complications in oral and maxillofacial surgery: management of hemostasis and bleeding disorders in surgical procedures. Oral Maxillofac Surg Clin North Am. 2011;23:387–94.
Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg. 2001;182:S21–8.
Maulaz A, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62:1217–20.
Mingarro-de-León A, Chaveli-López B, Gavaldá-Esteve C. Dental management of patients receiving anticoagulant and/or antiplatelet treatment. J Clin Exp Dent. 2014;6:e155–61.
Morimoto Y, Niwa H, Minematsu K. Hemostatic management of tooth extractions in patients on oral antithrombotic therapy. J Oral Maxillofac Surg. 2008;66:51–7.
Morimoto Y, Niwa H, Minematsu K. Risk factors affecting postoperative hemorrhage after tooth extraction in patients receiving oral antithrombotic therapy. J Oral Maxillofac Surg. 2011;69:1550–6.
Napeñas JJ, Oost F, deGroot A, Loven B, Hong C, Brennan MT, Lockhart PB, van Diermen DE. Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:491–9.
Onysko M, Holcomb N, Hornecker J. Antibiotic interactions: answers to 4 common questions. J Fam Pract. 2016;65:442–8.
Palareti G, Cosmi B. Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients. Thromb Haemost. 2009;102:268–78.
Singh T, Cuomo L, Cohen M, Ahmad HA, Aronow WS. Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents. Curr Clin Pharmacol. 2013;8:59–66.
Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 2012;120:2954–62.
Thean D, Alberghini M. Anticoagulant therapy and its impact on dental patients: a review. Aust Dent J. 2016;61:149–56.
Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 1998;158:1610–6.
Weltman N, Al-Attar Y, Cheung J, Duncan D, Katchky A, Azarpazhooh A, Abrahamyan L. Management of dental extractions in patients taking warfarin as anticoagulant treatment: a systematic review. J Can Dent Assoc. 2015;81:f20.
Wilson D, Harrison TR, Isselbacher J. Harrison’s principles of internal medicine. New York: McGraw-Hill; 2015.
World Health Organization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO technical report series. 1999. p. 889.
Yip J, Shen Y, Berndt MC, Andrews RK. Primary platelet adhesion receptors. IUBMB Life. 2005;57:103.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hanna, I.A., All-Atabakhsh, A., Valenza, J.A. (2019). Pharmacologic Management of Patients with Drug-Related Coagulopathies. In: Jeske, A. (eds) Contemporary Dental Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-99852-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-99852-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99851-0
Online ISBN: 978-3-319-99852-7
eBook Packages: MedicineMedicine (R0)